Johnson & White Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Johnson & White Wealth Management's ABBV Position: Q2 2026 in Review
Johnson & White Wealth Management increased its AbbVie (ABBV) stake by 0.59% in Q2 2026, buying an estimated $6.02K and bringing the position to 4,760 shares worth $1.2M. The position accounts for 0.45% of the portfolio, ranked #48.
Johnson & White Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.21M in Q3 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Johnson & White Wealth Management held 4,760 shares of AbbVie worth $1.2M as of Q2 2026.
- Johnson & White Wealth Management bought 28 AbbVie shares in Q2 2026, an estimated $6.02K.
- AbbVie made up 0.45% of Johnson & White Wealth Management's portfolio in Q2 2026, its #48 holding.
- Johnson & White Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
- Johnson & White Wealth Management's AbbVie position peaked at $1.21M in Q3 2024.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Johnson & White Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.